Becker's Healthcare October 15, 2024
A new study suggests that Medicare could save up to $366 million annually by introducing a new vial size for Alzheimer’s drug lecanemab, which is currently only available in single-use, 500- and 200-milligram vials.
The study, published in JAMA Internal Medicine Oct. 14 by researchers at the David Geffen School of Medicine at University of California in Los Angeles, revealed that weight-based dosing results in substantial medication waste of up to an estimated 5.8%....
Today's Sponsors
Today's Sponsor